UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Navigating Pregnancy for Employees in Civilian Rotary-Wing Aeromedicine

Aerospace medicine and human performance, 2022-12, Vol.93 (12), p.866-876

2022

Volltextzugriff (PDF)

MEDEX2015: Greater Sea-Level Fitness Is Associated with Lower Sense of Effort During Himalayan Trekking Without Worse Acute Mountain Sickness

High altitude medicine & biology, 2017-06, Vol.18 (2), p.152-162

2017

Volltextzugriff (PDF)

Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial

Journal of the American College of Cardiology, 2016-03, Vol.67 (10), p.1145-1154

2016

Volltextzugriff (PDF)

Monitoring Antiplatelet Therapy

Seminars in thrombosis and hemostasis, 2017-04, Vol.43 (3), p.311-319

2017

Volltextzugriff (PDF)

Morphine delays the onset of action of prasugrel in patients with prior history of ST-elevation myocardial infarction

Thrombosis and haemostasis, 2016-07, Vol.116 (1), p.96-102

2016

Volltextzugriff (PDF)

Relationship between degree of P2Y12 receptor blockade and inhibition of P2Y12-mediated platelet function

Thrombosis and haemostasis, 2010-06, Vol.103 (6), p.1210-1217

2010

Volltextzugriff (PDF)

Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome

Platelets (Edinburgh), 2019-02, Vol.30 (2), p.148-157

2019

Volltextzugriff (PDF)

Study of Two Dose Regimens of Ticagrelor Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease

Circulation (New York, N.Y.), 2018-09, Vol.138 (13), p.1290-1300

2018

Volltextzugriff (PDF)

Platelet P2Y12 Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human Model

Arteriosclerosis, thrombosis, and vascular biology, 2015-12, Vol.35 (12), p.2562

2015

Volltextzugriff (PDF)

Circulating MicroRNA Levels Indicate Platelet and Leukocyte Activation in Endotoxemia Despite Platelet P2Y12 Inhibition

International journal of molecular sciences, 2020-04, Vol.21 (8), p.2897

2020

Volltextzugriff (PDF)

Pharmacodynamic Effects of a 6-Hour Regimen of Enoxaparin in Patients Undergoing Primary Percutaneous Coronary Intervention (PENNY PCI Study)

Thrombosis and haemostasis, 2018-07, Vol.118 (7), p.1250-1256

2018

Volltextzugriff (PDF)

Offset of ticagrelor prior to coronary artery bypass graft surgery for acute coronary syndromes: effects on platelet function and cellular adenosine uptake

Platelets (Edinburgh), 2020-10, Vol.31 (7), p.945-951

2020

Volltextzugriff (PDF)

Prolonged enoxaparin therapy compared with standard-of-care antithrombotic therapy in opiate-treated patients undergoing primary percutaneous coronary intervention

Platelets (Edinburgh), 2021-05, Vol.32 (4), p.555-559

2021

Volltextzugriff (PDF)

Vessel wall, not platelet, P2Y12 potentiates early atherogenesis

Cardiovascular research, 2014-06, Vol.102 (3), p.429-435

2014

Volltextzugriff (PDF)

L-FABP directly interacts with PPARα in cultured primary hepatocytes

Journal of lipid research, 2009-08, Vol.50 (8), p.1663-1675

2009

Volltextzugriff (PDF)

Influence of body weight and body mass index on the chronic pharmacokinetic and pharmacodynamic responses to clinically available doses of ticagrelor in patients with chronic coronary syndromes

Vascular pharmacology, 2023-04, Vol.149, p.107145-107145, Article 107145

2023

Volltextzugriff (PDF)

Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor

Thrombosis and haemostasis, 2005-10, Vol.94 (4), p.831-838

2005

Volltextzugriff (PDF)

Ticagrelor potentiates adenosine-induced stimulation of neutrophil chemotaxis and phagocytosis

Vascular pharmacology, 2015-08, Vol.71, p.201-207

2015

Volltextzugriff (PDF)

Consistent platelet inhibition with ticagrelor 60 mg twice-daily following myocardial infarction regardless of diabetes status

Thrombosis and haemostasis, 2017, Vol.117 (5), p.940-947

2017

Volltextzugriff (PDF)

Comparison of the Metabolic Effects of Ritonavir-Boosted Darunavir or Atazanavir Versus Raltegravir, and the Impact of Ritonavir Plasma Exposure: ACTG 5257

Clinical infectious diseases, 2015-06, Vol.60 (12), p.1842-1851

2015

Volltextzugriff (PDF)

THROMBOINFLAMMATORY RESPONSE TO ON-PUMP CORONARY ARTERY BYPASS GRAFT SURGERY LEADS TO IMPAIRED PLATELET REACTIVITY IN PATIENTS WITH ACUTE CORONARY SYNDROME

Journal of the American College of Cardiology, 2022-03, Vol.79 (9), p.1094

2022

Volltextzugriff (PDF)

Inhibition of ADP-induced P-selectin expression and platelet-leukocyte conjugate formation by clopidogrel and the P2Y12 receptor antagonist AR-C69931MX but not aspirin

Thrombosis and haemostasis, 2002, Vol.88 (3), p.488-494

2002

Volltextzugriff (PDF)

Hirudin anticoagulation allows more rapid determination of P2Y₁₂ inhibition by the VerifyNow P2Y12 assay

Thrombosis and haemostasis, 2013-03, Vol.109 (3), p.550-555

2013

Volltextzugriff (PDF)

Indigenous Youth Mentorship Program: key implementation characteristics of a school peer mentorship program in Canada

Health promotion international, 2021-08, Vol.36 (4), p.913-923

2021

Volltextzugriff (PDF)

Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes. The TRACER Pharmacodynamic Substudy

Thrombosis and haemostasis, 2014-05, Vol.111 (5), p.883-891

2014

Volltextzugriff (PDF)

1 – 25 von 63

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(35)

Publikationsform

Sprache

Englisch
(63)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(35)
Science & Technology
(29)
Life Sciences & Biomedicine
(28)
Male
(22)
Female
(19)
Blood Platelets - Drug Effects
(14)
Hematology
(14)
Middle Aged
(13)
P2y
(12)
Platelet Aggregation - Drug Effects
(11)
Adult
(10)
Blood Platelets - Metabolism
(10)
Clopidogrel
(10)
Ticlopidine - Analogs & Derivatives
(10)
Aged
(9)
Platelet Aggregation Inhibitors - Pharmacology
(9)
Cardiovascular System & Cardiology
(8)
Ticagrelor
(8)
Adenosine - Analogs & Derivatives
(7)
Peripheral Vascular Disease
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Navigating Pregnancy for Employees in Civilian Rotary-Wing Aeromedicine

MEDEX2015: Greater Sea-Level Fitness Is Associated with Lower Sense of Effort During Himalayan Trekking Without Worse Acute Mountain Sickness

Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial

Monitoring Antiplatelet Therapy

Morphine delays the onset of action of prasugrel in patients with prior history of ST-elevation myocardial infarction

Relationship between degree of P2Y12 receptor blockade and inhibition of P2Y12-mediated platelet function

Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome

Study of Two Dose Regimens of Ticagrelor Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease

Platelet P2Y12 Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human Model

Circulating MicroRNA Levels Indicate Platelet and Leukocyte Activation in Endotoxemia Despite Platelet P2Y12 Inhibition

Pharmacodynamic Effects of a 6-Hour Regimen of Enoxaparin in Patients Undergoing Primary Percutaneous Coronary Intervention (PENNY PCI Study)

Offset of ticagrelor prior to coronary artery bypass graft surgery for acute coronary syndromes: effects on platelet function and cellular adenosine uptake

Prolonged enoxaparin therapy compared with standard-of-care antithrombotic therapy in opiate-treated patients undergoing primary percutaneous coronary intervention

Vessel wall, not platelet, P2Y12 potentiates early atherogenesis

L-FABP directly interacts with PPARα in cultured primary hepatocytes

Influence of body weight and body mass index on the chronic pharmacokinetic and pharmacodynamic responses to clinically available doses of ticagrelor in patients with chronic coronary syndromes

Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor

Ticagrelor potentiates adenosine-induced stimulation of neutrophil chemotaxis and phagocytosis

Consistent platelet inhibition with ticagrelor 60 mg twice-daily following myocardial infarction regardless of diabetes status

Comparison of the Metabolic Effects of Ritonavir-Boosted Darunavir or Atazanavir Versus Raltegravir, and the Impact of Ritonavir Plasma Exposure: ACTG 5257

THROMBOINFLAMMATORY RESPONSE TO ON-PUMP CORONARY ARTERY BYPASS GRAFT SURGERY LEADS TO IMPAIRED PLATELET REACTIVITY IN PATIENTS WITH ACUTE CORONARY SYNDROME

Inhibition of ADP-induced P-selectin expression and platelet-leukocyte conjugate formation by clopidogrel and the P2Y12 receptor antagonist AR-C69931MX but not aspirin

Hirudin anticoagulation allows more rapid determination of P2Y₁₂ inhibition by the VerifyNow P2Y12 assay

Indigenous Youth Mentorship Program: key implementation characteristics of a school peer mentorship program in Canada

Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes. The TRACER Pharmacodynamic Substudy

Suchergebnisse filtern